AVEO PHARMACEUTICALS INC's ticker is and the CUSIP is 053588909. A total of 3 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,073,000 | -33.5% | 1,719,300 | -10.1% | 0.01% | -46.2% |
| Q3 2019 | $1,614,000 | -0.8% | 1,911,400 | -20.9% | 0.01% | -13.3% |
| Q2 2019 | $1,627,000 | -3.2% | 2,417,400 | +17.9% | 0.02% | -21.1% |
| Q1 2019 | $1,681,000 | -39.5% | 2,049,600 | +18.1% | 0.02% | -20.8% |
| Q4 2018 | $2,777,000 | +7.4% | 1,735,900 | +122.3% | 0.02% | +20.0% |
| Q3 2018 | $2,585,000 | +208.8% | 780,900 | +110.9% | 0.02% | +185.7% |
| Q2 2018 | $837,000 | +100.2% | 370,200 | +156.7% | 0.01% | +75.0% |
| Q1 2018 | $418,000 | -49.3% | 144,200 | -51.2% | 0.00% | -33.3% |
| Q4 2017 | $825,000 | -47.4% | 295,600 | -31.2% | 0.01% | -57.1% |
| Q3 2017 | $1,568,000 | +743.0% | 429,700 | +414.0% | 0.01% | +600.0% |
| Q2 2017 | $186,000 | +1966.7% | 83,600 | +461.1% | 0.00% | – |
| Q1 2017 | $9,000 | +350.0% | 14,900 | +396.7% | 0.00% | – |
| Q4 2016 | $2,000 | -98.9% | 3,000 | -95.8% | 0.00% | -100.0% |
| Q2 2013 | $179,000 | – | 71,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 12,214 | $2,760,000 | 0.43% |
| Prosight Management, LP | 70,100 | $158,000 | 0.12% |
| GROUP ONE TRADING, L.P. | 370,200 | $837,000 | 0.01% |
| SIMPLEX TRADING, LLC | 1,156 | $261,000 | 0.00% |